← Evidence map

ReviewDrug safety2015

Safety and tolerability profile of second-line anti-tuberculosis medications.

Geetha Ramachandran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

46 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25676682